Peer Reviewed Publications 05.03.2018
Evolving Industry Partnerships and Investments in Cell and Gene Therapies
Devyn M.Smith, Emily J. Culme-Seymour, Chris Mason
Cell Stem Cell
Cell and gene therapies hold the promise of providing significant and durable health gains to patients in many disease states and have recently elicited significant investor and partner interest. We cover the current state of industry partnerships and investments, highlight what makes a partnership advantageous, and discuss implications for stem cell therapies.